Hepatic toxicity in south indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide

This publication has 10 references indexed in Scilit:

• A controlled trial of six months chemotherapy in pulmonary tuberculosis: First report: Results during chemotherapy
  Published by Elsevier ,2004
• Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy
  Tubercle, 1983
• Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man
  European Journal of Clinical Pharmacology, 1983
• Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis second report: the results up to 24 months
  Tubercle, 1982
• The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide
  Tubercle, 1977
• Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong
  Tubercle, 1976
• Isoniazid Liver Injury: Clinical Spectrum, Pathology, and Probable Pathogenesis
  Annals of Internal Medicine, 1976
• Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites
  Clinical Pharmacology & Therapeutics, 1975
• Co-operative controlled trial of a standard regimen of streptomycin,pas and isoniazid and three alternative regimens of chemotherapy in Britain A report from the British Medical Research Council
  Tubercle, 1973
• Jaundice after rifampicin
  Respiratory Medicine, 1970